Senores Pharmaceuticals IPO raises ₹261 crore from anchor investors ahead of public issue
5 days, 14 hours ago

Senores Pharmaceuticals IPO raises ₹261 crore from anchor investors ahead of public issue

Live Mint  

New Delhi, Dec 19 Senores Pharmaceuticals Ltd on Thursday said it has secured nearly ₹261 crore from anchor investors, ahead of its initial share-sale opening for public subscription. ICICI Prudential Mutual Fund, Mahindra Manulife Mutual Fund, Aditya Birla Sun Life Insurance Company, SBI General Insurance Company, and Troo Capital are among the anchor investors, according to a circular uploaded on the BSE website. According to the circular, Senores Pharmaceuticals has allotted about 66.66 lakh equity shares to 20 funds at ₹391 apiece, aggregating the transaction size to ₹260.63 crore. The Ahmedabad-based company's IPO is a combination of fresh issuance of shares worth ₹500 crore and an offer for sale of up to 21 lakh shares valued ₹82.11 crore, by promoters and other selling shareholders, at the upper end of the price band.

Company Crore Pti Shares Ipo Senores Pharmaceuticals Senores Investors Ahead  shares  issue  senores  ipo  public  raises  crore  facility  pharmaceuticals  anchor  company  investors  ahead

History of this topic

Senores Pharmaceuticals IPO: Should you subscribe? Check GMP, subscription
Trending News
2 days, 6 hours ago

Senores Pharmaceuticals IPO: Should you subscribe? Check GMP, subscription

India Today  

The Rs 582.11 crore initial public offering of Senores Pharmaceuticals is set to close for bidding on Tuesday, December 24, 2024, after opening for subscription on Friday. Before the public offering, Senores Pharmaceuticals raised Rs 260.6 crore from anchor investors by allocating 66.65 lakh shares at Rs 391 per share. Notable investors in the anchor book include Goldman Sachs, Societe …

Senores Pharma IPO: GMP, subscription status, review, other details. Apply or not?
2 days, 18 hours ago

Senores Pharma IPO: GMP, subscription status, review, other details. Apply or not?

Live Mint  

Senores Pharmaceuticals Limited's initial public offering opened for public subscription on Friday, December 20 and will close on Tuesday, December 24. Senores Pharma IPO latest GMP As of December 22, the grey market premium for the Senores Pharmaceutical public issue stands at ₹200 per share. Senores Pharma IPO subscription status The issue of Senores Pharma was subscribed 13.93 times at …

Senores Pharma IPO: GMP, subscription status to review. Apply or not as the issue gets fully booked on day one?
3 days, 22 hours ago

Senores Pharma IPO: GMP, subscription status to review. Apply or not as the issue gets fully booked on day one?

Live Mint  

Senores Pharma IPO: Bidding for the initial public offering of Senores Pharma Limited began on 20th December 2024 and will remain until 5:00 PM on 24 December 2024. According to Senores Pharma IPO subscription status, the public issue got fully subscribed on day one of bidding and received bids that were 1.78 times the offer. On what this Senores Pharma …

Senores Pharmaceuticals IPO: Check latest GMP, price band and should you apply?
5 days, 6 hours ago

Senores Pharmaceuticals IPO: Check latest GMP, price band and should you apply?

India Today  

Senores Pharmaceuticals' initial public offering, valued at Rs 582.11 crore, opened for bidding on December 20, 2024, and will close on December 24. The IPO consists of a fresh issue of Rs 500 crore and an offer-for-sale of up to 21 lakh shares by promoters and existing shareholders. According to market watchers, the latest grey market premium for the IPO …

IPO Update: Kolkata-based Crizac refiles IPO papers with SEBI
1 month ago

IPO Update: Kolkata-based Crizac refiles IPO papers with SEBI

Live Mint  

IPO Update: Kolkata-based Crizac has refiled papers with market regulator Securities and Exchange Board of India for an initial public offering. In the six months ending September 30, 2023, as well as during the last three fiscal years, Crizac Limited facilitated enrollment applications from over 75 countries through its registered agents using its technology platform. The company's pro forma consolidated …

Glenmark Pharmaceuticals Q2 results 2024 on 16 Nov, 2024: profit at ₹354.21Cr, Revenue increased by 7.06% YoY
1 month, 1 week ago

Glenmark Pharmaceuticals Q2 results 2024 on 16 Nov, 2024: profit at ₹354.21Cr, Revenue increased by 7.06% YoY

Live Mint  

Glenmark Pharmaceuticals Q2 Results 2024:Glenmark Pharmaceuticals declared its Q2 results on 14 Nov, 2024, reporting a significant turnaround with a profit of ₹354.21 crore. As of 16 Nov, 2024, Glenmark Pharmaceuticals has a market cap of ₹43,279.2 crore, with a 52-week high of ₹1,830.95 and a low of ₹746.55. The consensus recommendation among analysts as of 16 Nov, 2024, is …

Top News on Nov 14: Market slides for 6th day, Reliance, Disney complete transaction, Q2 results, GRAP 3 In Delhi, more
1 month, 1 week ago

Top News on Nov 14: Market slides for 6th day, Reliance, Disney complete transaction, Q2 results, GRAP 3 In Delhi, more

Live Mint  

From Sensex, Nifty 50 sliding for 6th day to Reliance-Disney completing transaction to imposition of GRAP 3 In Delhi, here are today's top stories. Reliance, Disney complete transaction for $8.5-billion merger deal to create India’s largest media powerhouse Reliance-Disney merger: Mukesh Ambani-led Reliance Industries has completed the merger of its media assets with the India business of global media house …

Gland Pharma Q2 net declines 16% to ₹163.5 cr.
1 month, 2 weeks ago

Gland Pharma Q2 net declines 16% to ₹163.5 cr.

The Hindu  

Generic injectable-focused Gland Pharma consolidated net profit declined almost 16% to ₹163.5 crore for the quarter ended September compared to the ₹194 crore in the year earlier period. The lower net profit came on a more than 2% increase in the revenue from operations at ₹1,405.8 crore. Looking ahead, we remain focused on our strategic priorities, which include entering new …

Sun Pharma net profit up 29% in Q1 FY25 on cut in raw material cost
4 months, 3 weeks ago

Sun Pharma net profit up 29% in Q1 FY25 on cut in raw material cost

The Hindu  

Sun Pharma reported Q1 net profit grew 29% to ₹2,878.94 crore from ₹2,232.05 crore in the year-earlier period on shrinking material costs and revenue expansion The company’s revenue from operations rose 6% to ₹12,652.7 crore in Q1 FY25 from ₹11,940.8 crore in the same quarter of the previous year. Cost of materials consumed dropped 16% in the reporting quarter to …

Emcure Pharmaceuticals IPO debuts tomorrow: All you need to know ahead of listing
5 months, 2 weeks ago

Emcure Pharmaceuticals IPO debuts tomorrow: All you need to know ahead of listing

Hindustan Times  

Emcure Pharmaceuticals IPO listing is scheduled for tomorrow. Emcure Pharma IPO saw strong response and as per BSE data, the subscription status was 67.87 times. Emcure Pharmaceuticals IPO GMP Ahead of the listing, Emcure Pharma IPO GMP on July 9 is +352 which indicates that the company's share price was trading at a premium of ₹352 in the grey market, …

IPO: Ixigo’s Parent Company Raises Rs 333 Crore From Anchor Investors Ahead Of Maiden Offer
6 months, 2 weeks ago

IPO: Ixigo’s Parent Company Raises Rs 333 Crore From Anchor Investors Ahead Of Maiden Offer

ABP News  

Parent company of Travel booking platform ixigo, Le Travenues Technology Ltd, announced on Friday that it raised funds worth Rs 333 crore from anchor investors, a weekend ahead of the company’s initial public offering. The firm, based out of Gurgaon, allotted 3.58 crore equity shares to 23 funds at the cost of Rs 93 per share, coming up to Rs …

Innova Captab IPO: Check price band, issue date, GMP and other details
1 year ago

Innova Captab IPO: Check price band, issue date, GMP and other details

Live Mint  

Mumbai-based pharmaceutical firm, Innova Captab, has set the price range for its upcoming initial public offering at ₹426 to ₹448 per share. Innova Captab's upcoming IPO will comprise a fresh equity share issue valued at up to ₹400 crore, alongside an offer-for-sale featuring up to 9,600,000 equity shares by the promoter and selling shareholders. As an integrated pharmaceutical firm in …

Shiva Pharmachem files DRHP to raise ₹900 crore via IPO
1 year, 4 months ago

Shiva Pharmachem files DRHP to raise ₹900 crore via IPO

Live Mint  

Speciality chemicals manufacturer Shiva Pharmachem plans to raise ₹900 crore from the primary market and has filed preliminary papers for its maiden public issue. The Vadodara-based Shiva Pharmachem has filed its Draft Red Herring prospectus with capital market regulator Securities & Exchange Board of India for an initial public offering. Shiva Pharmachem IPO is entirely an offer for sale of …

Senco Gold collects over ₹121 crore from anchor investors ahead of IPO
1 year, 5 months ago

Senco Gold collects over ₹121 crore from anchor investors ahead of IPO

Live Mint  

Jewellery retail player Senco Gold Ltd on Monday said it has mobilised ₹121.5 crore from anchor investors ahead of its initial share sale. Senco Gold Limited has allotted 38,32,807 equity shares to 21 anchor investors and raised ₹ 121.50 crore ahead of company’s proposed IPO, the upper price band of ₹ 317 per equity share with face value of ₹10 …

Realty, PSU Bank, FMCG, Pharma drag Sensex by 130 pts; Nifty down 50 pts
1 year, 7 months ago

Realty, PSU Bank, FMCG, Pharma drag Sensex by 130 pts; Nifty down 50 pts

Live Mint  

Indian benchmark indices started in green but turned red towards the end of today's session. ZYDUS LIFESCIENCES More Information SBI Quarter 4 results: Net profit jumps 83% YoY to ₹16,695 crore; NII up 29% to ₹40,392 crore State Bank of India, the country’s largest bank, on Thursday reported a net profit of ₹16,694.5 crore for the quarter ended March 2023, …

Mankind Pharma raises ₹1,298 cr from anchor investors ahead of IPO
1 year, 8 months ago

Mankind Pharma raises ₹1,298 cr from anchor investors ahead of IPO

Live Mint  

Mankind Pharma on Monday said it has raised ₹1,298 crore from anchor investors ahead of its initial share sale that opens for subscription on 25 April, 2023. “Trading Members of the Exchange are hereby informed that, under Anchor Investors portion in the Public Issue of Mankind Pharma Limited, 1,20,17,652 equity shares have been subscribed today at Rs. Canada Pension Plan …

Mankind Pharma IPO: From key dates to price band, all you need to know
1 year, 8 months ago

Mankind Pharma IPO: From key dates to price band, all you need to know

Live Mint  

Mankind Pharma Ltd's initial public offer will open for subscription on Tuesday, April 25, and close on Thursday, April 27. The company has fixed the price band at Rs 1,026 to Rs 1,080 per equity share for the proposed initial public offer. The OFS comprises about 37.1 lakh shares by Ramesh Juneja, 35.1 lakh shares by Rajeev Juneja, 28 lakh …

Top Indian pharma stocks to buy/hold: BNP Paribas shares preferred picks
1 year, 11 months ago

Top Indian pharma stocks to buy/hold: BNP Paribas shares preferred picks

Live Mint  

Brokerage and research firm BNP Paribas continues to be selective with US generics and does not expect the profitability of this business to materially improve for drugmakers. With the softening of crude oil price and normalisation of supply chain issues, BNP Paribas expects raw material and freight costs to gradually moderate from elevated levels. The brokerage house has Buy ratings …

This Pharma Stock Surges 17% As Board To Consider Share Buyback; Know Details
2 years, 5 months ago

This Pharma Stock Surges 17% As Board To Consider Share Buyback; Know Details

News 18  

Marksans Pharma Share Buyback: Marksans Pharma shares rallied more than 17 per cent to Rs 50 apiece on the BSE in Tuesday’s trading session after the company informed about its buyback offer. A meeting of the board of directors of Marksans Pharma is scheduled to be held on Friday, July 8, 2022 to consider the proposal for the buyback of …

Delhivery IPO Likely To Open on May 11; Issue Size Reduced Amid Volatile Markets
2 years, 7 months ago

Delhivery IPO Likely To Open on May 11; Issue Size Reduced Amid Volatile Markets

News 18  

India’s largest fully integrated logistics company, Delhivery’s IPO, is likely to open for subscription on May 11 and close on May 13. Fosun group-owned China Momentum Fund, via its affiliate Deli CMF Pte Ltd, will sell up to Rs 200 crore. Kapil Bharati will sell shares worth Rs 5 crore, Mohit Tandon will sell shares worth Rs 40 crore and …

Q4 Results Preview: Margins of Pharma companies likely to remain under pressure in the March quarter
2 years, 8 months ago

Q4 Results Preview: Margins of Pharma companies likely to remain under pressure in the March quarter

Live Mint  

The Indian pharmaceuticals sector has been under pressure from the ongoing Russia-Ukraine war as a majority of pharma companies have a strong presence in both countries. The report estimates EBITDA in 4QFY22E to be sequentially lower for the majority of Indian generic pharma companies on account of lower gross margins due to an increase in raw material costs and sustained …

Delhivery Gets Sebi’s Go-Ahead To Raise Rs 7,460 Cr Via IPO
2 years, 11 months ago

Delhivery Gets Sebi’s Go-Ahead To Raise Rs 7,460 Cr Via IPO

ABP News  

New Delhi: Delhivery, the supply chain firm, has received Sebi’s approval to raise Rs 7,460 crore through an initial public offering. The IPO comprises fresh issuance of equity shares worth Rs 5,000 crore and an offer for sale component of Rs 2,460 crore by existing shareholders, according to the draft red herring prospectus, PTI reported. According to the draft papers, …

Online medical store PharmEasy targets $842 million IPO
3 years, 1 month ago

Online medical store PharmEasy targets $842 million IPO

The Hindu  

Indian digital healthcare platform PharmEasy filed on Wednesday, November 10, 2021, for an initial public offering of up to 62.50 billion rupees,becoming the latest startup in the country to pursue a domestic stock listing. API Holdings Ltd, PharmEasy's parent, may also consider a further issue of equity shares via a private placement of up to12.50 billion rupees, the company said …

Stocks to Watch: HDFC Bank, Zee Entertainment, Piramal Enterprise, Max Healthcare and More
3 years, 2 months ago

Stocks to Watch: HDFC Bank, Zee Entertainment, Piramal Enterprise, Max Healthcare and More

News 18  

Indian markets on Thursday, tracking global cues is expected to open in the negative territory. HDFC AMC: Foreign promoter Standard Life Investments sold 1,06,50,000 equity shares in the company at Rs 2,873.79 per share, whereas T Rowe Price Emerging Markets Stock Fund acquired 15,19,557 equity shares at Rs 2,871.05 per share on the BSE, the bulk deals data showed Max …

Godavari Biorefineries files draft IPO papers with Sebi
3 years, 2 months ago

Godavari Biorefineries files draft IPO papers with Sebi

Live Mint  

Godavari Biorefineries has filed draft red herring prospectus with market regulator Securities and Exchange Board of India to raise funds via IPO. The preliminary papers stated that the public issue will comprise a fresh issue of equity shares worth ₹370 crore and an offer for sale of 65,58,278 equity shares by promoters and investors. The OFS consists of sale of …

MTAR Technologies' IPO oversubsribed nearly three times on opening day; bids for 2.17 crore shares placed
3 years, 9 months ago

MTAR Technologies' IPO oversubsribed nearly three times on opening day; bids for 2.17 crore shares placed

Firstpost  

While retail investors led the charge placing bids 5.66 times the portion reserved for them, the portion reserved for non-institutional investors has 76% subscription The Rs 596 crore initial public offering by Hyderabad-based MTAR Technologies was over-subscribed nearly three times the issue size within hours of opening for bids by public investors on Monday, reports said. The IPO has received …

More specialty chemical companies line up to launch IPOs
4 years ago

More specialty chemical companies line up to launch IPOs

Live Mint  

Unlisted specialty chemical makers are looking to launch initial public offerings in the coming months, after market investors showed a distinct preference for such firms. Surat-based Anupam Rasayan plans to file its draft IPO papers soon, looking to raise up to ₹750-800 crore, said two people aware of the matter. Another specialty chemical maker, Mumbai-based Laxmi Organics, on Tuesday evening …

Discover Related